Extrapulmonary neuroendocrine carcinoma (EP-NEC) is a rare and aggressive cancer that is often misunderstood and diagnosed late.

 

In this video for patients and care partners, Jessica Thomas, Director of Patient Education at the Neuroendocrine Tumour Research Foundation, highlights why specialist care is essential for people with EP-NEC. She introduces the concept of “thrivership” and explains how finding the right support can help with informed decision-making and values-aligned care.

 

Jessica emphasises the importance of expert treatment and connection with advocacy organisations, and explores the possibilities offered by evolving therapeutic options.

 

Clinical takeaways

 

  • EP-NEC is a distinct and aggressive subtype of neuroendocrine cancer, characterised by late diagnosis, frequent mis-categorisation, and mis-understanding 
  • Delays in diagnosis, inconsistent treatment pathways, limited specialist access, and patient confusion underscore the complexity and burden of EP-NEC 
  • Given the complexity of EP-NEC, patients require expert care from specialists knowledgeable in neuroendocrine carcinoma, as generic care is insufficient to address the aggressive nature and unique challenges of this disease 
  • Thrivership in the context of EP-NEC includes finding agency around the things that can be controlled, understanding the disease, the urgency of diagnosis and management, and evolving treatment options
  • To increase awareness and understanding of the complex nature and burden of disease associated with EP-NEC 
  • To share patient and HCP perspectives on obtaining a diagnosis of EP-NEC and subsequent treatment experiences 
  • To understand the potential future treatment options in EP-NEC 

Jessica Thomas, LCSW is a patient education leader and licensed clinical social worker with more than 20 years of experience walking alongside individuals and families living with cancer and chronic illness. She currently serves as Director of Patient Education at the Neuroendocrine Tumor Research Foundation (NETRF), where she helps turn the latest research and medical knowledge into clear, practical resources for people affected by neuroendocrine cancer. 

Jessica’s work focuses on meeting patients and caregivers where they are—acknowledging the uncertainty, fear, and questions that come with a diagnosis, while also helping people feel informed, supported, and empowered. She leads educational programs that include national conferences, virtual and in-person events, podcasts, patient guides, and digital tools, all designed to make complex information more understandable and usable in everyday life. 

Before joining NETRF, Jessica spent much of her career as a mental health clinician, supporting individuals coping with life-changing diagnoses, long-term treatment, and the emotional impact of serious illness. That clinical foundation continues to shape her approach to patient education, with an emphasis on resilience, communication, and quality of life—not just disease management. 

Jessica is deeply committed to amplifying patient and caregiver voices and believes that education is most powerful when it is compassionate, accessible, and grounded in real lived experience. 

Programme summary
  • clock Duration 4 MIN
  • clock Language(s) flag
Watch the video now
Other episodes of this series
Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC)

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC)

Insights for patients and care partners 

Thriving beyond an EP-NEC diagnosis

Thriving beyond an EP-NEC diagnosis

Perspectives on treatment and care 

Current Episode
Share this programme
This educational programme is supported by an Independent Educational Grant from Boehringer Ingelheim 
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Boehringer Ingelheim 
Endorsement
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
NET CONNECT

NET CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Ipsen, Eisai Europe Limited, ITM and Boehringer Ingelheim

Meet the experts Independent IME approved

Other programmes of interest

eks
EKS / On-demand webinar
Oncology 
Multiple Myeloma: Is it time to rethink how we sequence treatments?

On-demand materials from an Experts Knowledge Share event

Experts
Prof. Karthik Ramasamy, Dr Joshua Richter, Dr Faisal Basheer, Dr Andrew Charlton
  • download Downloadable
    Resources
  • clock 80 MIN
  • calendar Mar 2026

This programme has been sponsored by Menarini Stemline and is intended for HCPs in the UK only    MAT-GB-SEL-00774
conference-update Conference update

Episode

2

of 2

episode
Oncology Rare diseases Endocrinology 
Actualités du Congrès l’ENETS 2026

Points de vue d’experts sur les dernières données concernant le cancer neuroendocrinien

Experts
Prof. Louis de Mestier, Prof. Timon Vandamme, Dr Alice Durand
  • clock 5 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

Cette vidéo est soutenue par une subvention indépendante à visée éducative d’Ipsen.  Les contenus publiés sur ce site internet sont sous la responsabilité de leurs auteurs. Certaines données scientifiques publiées sur ce site sont susceptibles de ne pas être validées par la commission d’Autorisation de Mise sur le Marché, et ne doivent pas être mises en pratique. Elles doivent être lues et comprises avec le plus grand discernement et sont données dans leur cadre de la diffusion de l’information sur l’état actuel de la recherche auprès de la communauté scientifique internationale  
conference-update Conference update

Episode

1

of 2

episode
Oncology Rare diseases Endocrinology 
Update from ENETS 2026

Experts share their views on latest data in neuroendocrine cancer

Experts
Prof. Louis de Mestier, Prof. Timon Vandamme, Dr Alice Durand
  • clock 5 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

This educational programme is supported by an Independent Educational Grant from Ipsen. The content published on this website is under the responsibility of its authors. Some scientific data published on this website may not have been validated by the relevant Marketing Authorisation Committees and should not be put into practice. It should be read and understood with the utmost discernment and is provided for the purpose of disseminating information on the current state of research to the international scientific community.
conference-update Conference update
Oncology 
Update from ESGO 2026 – PYNNACLE Phase 2 study: Interim results from the ovarian cancer cohort

Clinical insights and expert discussion

Experts
Prof. Domenica Lorusso, Prof. Jean-Sebastien Frenel
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Mar 2026

This programme has been sponsored by PMV Pharma and is intended for HCPs only.
publication Scientific Publication
Oncology 
ADCs in HER2+ metastatic breast cancer and management of adverse events

Consensus-based guidance for clinicians and patients

Experts
Prof. Javier Cortés, Prof. Giuseppe Curigliano, Prof. Shaheenah Dawood, Dr Grażyna Suchodolska, Dr Sara Tolaney, Carla Whitbread
Endorsed by
EONS - European Oncology Nursing Society Europa Donna
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Feb 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from AstraZeneca